Amgen Inc (AMGN.O), one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund.
Gilead Sciences
Breaking News
- IBM's Acquisition of HashiCorp for $6.4 Billion Confirmed, Aimed at Strengthening Cloud Capabilities
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- TikTok Voluntarily Suspends New App's Task and Reward Program After EU Regulators Express Concern Over Addictive Effects Among Young Users
France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- FAA Investigates Boeing’s Alleged Retaliation Against 2 Engineers Who Conveyed Safety Concerns in 2022
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Russia's Surprising Economic Strength to Last Another 18 Months Despite Western Sanctions and Ukraine War, Think Tank Says
- China Shows Heavy Support for Hong Kong Economy After Pressuring the Country to Enact New Security Law
